Press Release - July 2026

• The combined revenue of private clinical analysis laboratories reached €1.73 billion in 2025, excluding those located in medical centres with non-outsourced management. This was up 3% year-over-year, following 5% growth in the previous fiscal year.

• The business concentration process continued to advance, as the leading groups expanded, driven by acquisitions and integration transactions between operators. The top five groups accounted for over 35% of the combined revenue of private laboratories.

• INFORMA's DBK Sectoral Observatory recently published these insights in the 'Clinical Analysis' Sectoral Report.

Madrid, 9 July 2026.- According to INFORMA's (Cesce's subsidiary) DBK Sectoral Observatory—a leading provider of business, financial, sectoral, and marketing information in Spain and Portugal—revenue at private clinical analysis laboratories maintained the sustained growth trend seen in recent fiscal years in 2025. This was driven by rising demand for diagnostic services amid greater public awareness of health prevention and monitoring, and by structural constraints in the public healthcare system.

Revenue at private laboratories, excluding those located in medical centres with non-outsourced management, rose 5% in 2024 and 3% in 2025, reaching €1.73 billion in the latest fiscal year.

Including both private laboratories and laboratories located in medical centres with non-outsourced management, the total market rose to €3.83 billion, with private laboratories accounting for around 45% of that figure.

The number of healthcare centres authorised to conduct clinical analysis and registered in the Ministry of Health's General Register stood at close to 1,800 in June 2026, including both public and private centres. Of this total, 829 were specialist diagnostic centres for clinical analysis, of which around twenty were publicly owned, while the remaining more than 800 were run by private companies.

The business structure is characterised by a majority of small companies operating a single laboratory, alongside a small number of corporate groups, some of which are subsidiaries of foreign-origin multinational groups.

In recent years, the sector recorded a rising degree of concentration, as the leading groups expanded their business, mainly driven by the acquisition of smaller operators.

The top five competitors by revenue accounted for over 35% of the combined turnover of private laboratories. This figure stood at close to 50% when considering the top ten operators.

Data Synthesis, 2025

(a) excludes non-outsourced management laboratories located in medical centres.

(b) calculated on the total value of the clinical analysis market, including non-outsourced management laboratories located in medical centres.